- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06157073
Efficacy and Safety of Automated Closed-loop Ventilator vs Conventional Open-loop Ventilator in the Emergency Department (AVAC)
A Randomized, Controlled Trial to Evaluate the Efficacy and Safety of Fully Automated Closed-loop Ventilator Versus Conventional Open-loop Ventilator in Ventilated Patients in the Emergency Department
Study Overview
Status
Intervention / Treatment
Detailed Description
Invasive mechanical ventilation is a lifesaving intervention for patients with respiratory failure in the emergency department (ED). Recent technological advancements have introduced closed-loop automated ventilators as a potential alternative to open-loop conventional ventilators. However, the efficacy and safety of closed-loop automated ventilators in the emergency setting remains understudied. This research aims to evaluate the efficacy and safety of closed-loop automated ventilator compared to open-loop conventional ventilator in intubated and ventilated patients in the ED.
A randomized controlled trial will be conducted in an ED of a tertiary university-affiliated hospital. Eligible patients are 18 years or older, decision made by treating physicians to intubate and mechanically ventilate. Some of exclusion criteria are pregnancy, heart failure, metabolic acidosis, circulatory shock, life-threatening asthma and morbid obesity. The primary measure of efficacy is the duration of ventilation within a predefined range of acceptable respiratory parameters between automated and conventional ventilation. Secondary outcome measures are; number of manual adjustments required to attain targeted settings in automated and conventional ventilators, PaO2/FiO2 ratio (PF ratio), arterial blood gas results, vital signs, breath-by-breath analysis, and rate of ventilator dyssynchrony. The ventilator used in the intervention arm is the closed-loop automated ventilator Hamilton C6s INTELLIVENT-ASV (Hamilton Medical AG, Switzerland). Hamilton C1 ASV is chosen as the open-loop conventional comparator as it is similar to Hamilton C6s INTELLIVENT-ASV, without the INTELLIVENT software.
Based on Lellouche et al, the calculated total sample size with a dropout rate of 10% is 132. The data is analysed based on the intention-to-treat (ITT) and per-protocol (PP) principles. The primary endpoint measurements are reported as areas under the curves (AUC) within the predefined range of acceptable respiratory parameters. Between-group differences in continuous variables are analysed using independent t-test or Mann-Whitney U test. Between-group differences in categorical variables are analysed using chi-square test.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dr Muhaimin, MMed
- Phone Number: +60173600157
- Email: muhaimin@um.edu.my
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Decision made by treating physicians to intubate and mechanically ventilate
Exclusion Criteria:
- Suspected or confirmed pregnancy.
- Known right ventricular heart failure upon assessment for recruitment.
- Severe metabolic acidosis upon intubation (pH <7.2 or bicarbonate <12 mmol/L)
- Circulatory shock requiring noradrenaline more than 0.5 mcg/kg/min upon assessment for recruitment.
- Severe or acute life-threatening asthma.
- Patients with chest wall deformities that would affect ventilation (e.g. severe kyphoscoliosis, diaphragmatic hernia, flail chest, trauma, pectus excavatum or carinatum, ankylosing spondylitis
- Patients with previous lobectomy or pneumonectomy.
- Patients with pneumothorax or other condition that requires chest drainage tube.
- Patients with body mass index > 40 kg/m2.
Manufacturer's contraindications:
- Difference in oxygen saturation between pulse oximetry (SpO2) and arterial sample (SaO2) of more than 5% (due to unreliable sensor).
- Difference in carbon dioxide level between end-tidal sensor (ETCO2) and arterial sample (PaCO2) of more than 5 mm Hg (due to unreliable sensor).
- Known pneumothorax and bronchopulmonary fistula upon assessment for recruitment.
- Participation in another interventional trial.
- Do-not-attempt-resuscitation (DNAR) order.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Open-loop ventilator
Prior to the rapid sequence intubation, patients' gender and height are set on the ventilator.
The physician in-charge will setup the ventilator based on the lung condition, following the research protocol.
Patients will be connected to this ventilator upon securing the airway.
Ventilator setting parameters will be manually adjusted by the in-charge physician following local guidelines.
|
Conventional closed-loop ventilator with manual adjustments by the physician in charge
|
|
Experimental: Closed-loop ventilator
Prior to the rapid sequence intubation, patients' gender and height are set on the ventilator.
Patients' condition settings are selected depending on the lung condition.
The sensors for end-tidal carbon dioxide (EtCO2) and oxygen saturation (SpO2) will be connected.
Patients will be connected to this ventilator upon securing the airway.
Ventilator setting parameters will be set following the study protocol.
|
Fully automated closed-loop ventilator using the INTELLIVENT software
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of ventilation within a predefined range of acceptable respiratory parameters
Time Frame: Every 30 seconds for 240 minutes
|
Duration of ventilation (in minutes) within predefined acceptable tidal volume (TV), plateau pressure, EtCO2 and SpO2
|
Every 30 seconds for 240 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manual adjustments of ventilator settings
Time Frame: Any time the manual adjustment is performed throughout the 4-hour study period
|
Frequency of manual adjustments of ventilator settings and the parameters requiring adjustments
|
Any time the manual adjustment is performed throughout the 4-hour study period
|
|
Physiological data - blood pressure
Time Frame: Mean hourly for 4 hours
|
Patient's blood pressure in mmHg
|
Mean hourly for 4 hours
|
|
Physiological data - respiratory rate
Time Frame: Mean hourly for 4 hours
|
Patient's respiratory rate in breaths per minute
|
Mean hourly for 4 hours
|
|
Physiological data - heart rate
Time Frame: Mean hourly for 4 hours
|
Patient's heart rate in beats per minute
|
Mean hourly for 4 hours
|
|
Biochemical data - pH
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
Arterial pH levels
|
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
|
Biochemical data - CO2 and O2
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
Arterial partial pressure of carbon dioxide and oxygen in mmHg
|
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
|
Biochemical data - bicarbonate
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
Arterial bicarbonate levels in mmol/L
|
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
|
|
Patient outcome - mechanical ventilation
Time Frame: Assessed from time of intubation to time of successful extubation or death from any cause, whichever came first, assessed up to 28 days
|
Duration of mechanical ventilation
|
Assessed from time of intubation to time of successful extubation or death from any cause, whichever came first, assessed up to 28 days
|
|
Patient outcome - LOS ED
Time Frame: Assessed from time of triage to time patient leaves ED or death, whichever comes first, up to 7 days
|
Length of stay in emergency department
|
Assessed from time of triage to time patient leaves ED or death, whichever comes first, up to 7 days
|
|
Patient outcome - LOS ICU
Time Frame: Assessed from time of admission into the ICU to time of transfer to general ward or death, whichever comes first up to 28 days
|
Length of intensive care unit stay
|
Assessed from time of admission into the ICU to time of transfer to general ward or death, whichever comes first up to 28 days
|
|
Patient outcome - LOS hospital
Time Frame: Assessed from time of triage in ED to time of discharge or in-hospital death, whichever comes first up to 28 days
|
Length of hospital stay
|
Assessed from time of triage in ED to time of discharge or in-hospital death, whichever comes first up to 28 days
|
|
Mortality rate
Time Frame: At 14 and 28 days after recruitment
|
Number and percentage of deaths
|
At 14 and 28 days after recruitment
|
|
Number of patients developing ARDS and pneumothorax
Time Frame: At anytime within the 4-hour intervention or upon discharge or diagnosis of complications
|
Development of complications (pneumothorax, ARDS) during study and throughout admission
|
At anytime within the 4-hour intervention or upon discharge or diagnosis of complications
|
|
Ventilator data - airway pressures
Time Frame: Every 30 seconds for 240 minutes
|
Ventilator parameters: mean and peak airway pressures in cmH20
|
Every 30 seconds for 240 minutes
|
|
Ventilator data - FiO2
Time Frame: Every 30 seconds for 240 minutes
|
Ventilator parameters: fraction of inspired oxygen (FiO2)
|
Every 30 seconds for 240 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Khadijah Poh, MMed, University of Malaya
Publications and helpful links
General Publications
- Lellouche F, Bouchard PA, Simard S, L'Her E, Wysocki M. Evaluation of fully automated ventilation: a randomized controlled study in post-cardiac surgery patients. Intensive Care Med. 2013 Mar;39(3):463-71. doi: 10.1007/s00134-012-2799-2. Epub 2013 Jan 22.
- Arnal JM, Garnero A, Novonti D, Demory D, Ducros L, Berric A, Donati S, Corno G, Jaber S, Durand-Gasselin J. Feasibility study on full closed-loop control ventilation (IntelliVent-ASV) in ICU patients with acute respiratory failure: a prospective observational comparative study. Crit Care. 2013 Sep 11;17(5):R196. doi: 10.1186/cc12890.
- Clavieras N, Wysocki M, Coisel Y, Galia F, Conseil M, Chanques G, Jung B, Arnal JM, Matecki S, Molinari N, Jaber S. Prospective randomized crossover study of a new closed-loop control system versus pressure support during weaning from mechanical ventilation. Anesthesiology. 2013 Sep;119(3):631-41. doi: 10.1097/ALN.0b013e3182952608.
- Savioli G, Ceresa IF, Gri N, Bavestrello Piccini G, Longhitano Y, Zanza C, Piccioni A, Esposito C, Ricevuti G, Bressan MA. Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions. J Pers Med. 2022 Feb 14;12(2):279. doi: 10.3390/jpm12020279.
- Angotti LB, Richards JB, Fisher DF, Sankoff JD, Seigel TA, Al Ashry HS, Wilcox SR. Duration of Mechanical Ventilation in the Emergency Department. West J Emerg Med. 2017 Aug;18(5):972-979. doi: 10.5811/westjem.2017.5.34099. Epub 2017 Jul 11.
- Chelly J, Mazerand S, Jochmans S, Weyer CM, Pourcine F, Ellrodt O, Thieulot-Rolin N, Serbource-Goguel J, Sy O, Vong LVP, Monchi M. Automated vs. conventional ventilation in the ICU: a randomized controlled crossover trial comparing blood oxygen saturation during daily nursing procedures (I-NURSING). Crit Care. 2020 Jul 22;24(1):453. doi: 10.1186/s13054-020-03155-3.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023317-12254
- NMRR ID-23-03290-LRC (Registry Identifier: National Medical Research Register)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ARDS
-
Guy's and St Thomas' NHS Foundation TrustRecruiting
-
University Hospital, Clermont-FerrandAZUREA groupCompleted
-
West China HospitalCompleted
-
Pamukkale UniversityCompleted
-
Southeast University, ChinaActive, not recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Hamilton Medical AGTerminated
-
Southeast University, ChinaUnknown
-
University of TorontoSunnybrook Health Sciences Centre; Unity Health TorontoCompleted
-
Southeast University, ChinaRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
Clinical Trials on Open-loop ventilator
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
-
University of Texas at AustinRecruitingMild Cognitive ImpairmentUnited States
-
Prasad Shirvalkar, MD, PhDNational Institute of Neurological Disorders and Stroke (NINDS); United States...Active, not recruitingChronic Pain | Spinal Cord Injuries | Phantom Limb Pain | Post Stroke PainUnited States
-
Stanford UniversityCompletedParkinson DiseaseUnited States
-
University of VirginiaDexCom, Inc.; Insulet Corporation; Abbott Diabetes Care; University of California...CompletedType 1 Diabetes MellitusUnited States
-
Hamilton Medical AGCompletedRespiratory Failure | Self EfficacyBelgium
-
University Hospital, CaenAbbott; Ypsomed AGNot yet recruiting
-
Tsinghua UniversityPeking Union Medical College Hospital; Beijing Tiantan Hospital; Beijing Pins... and other collaboratorsRecruiting
-
MedtronicNeuroCompleted
-
University of VirginiaDexCom, Inc.; Insulet Corporation; Abbott Diabetes Care; University of California...CompletedType 1 Diabetes MellitusUnited States